{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:30:03Z","timestamp":1791811803467,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972731"],"award-info":[{"award-number":["81972731"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The risk for recurrence and metastasis after treatment for urothelial carcinoma of the bladder (UCB) is high. Therefore,\u00a0identifying efficient prognostic markers and novel therapeutic targets is urgently needed. Several long noncoding RNAs (lncRNAs) have been reported to be correlated with UCB progression. In this study, we found that the subtype-specific lncRNA MIR4435-2 host gene (MIR4435-2HG) plays a novel oncogenic role in UCB.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>RNA-Seq data of TCGA\/BLCA were analyzed. The expression of MIR4435-2HG was measured by qRT-PCR in 16 pairs of bladder cancer tissues and adjacent normal tissues. The clinical relecance of MIR4435-2HG was validated via in situ hybridization performed on an in-house cohort of 116 UCB patient samples. RNA pull-down followed by mass spectrometry was performed to identify MIR4435-2HG-binding proteins. To identify signaling pathways involved in MIR4435-2HG activity, comprehensive <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> studies and RNA-Seq assays were performed using UCB cells in which MIR4435-2HG expression was knocked down or exogenously overexpressed. In addition, we performed RNA immunoprecipitation and Western blot analyses to validate the identified MIR4435-2HG-binding proteins and to\u00a0determine the molecular mechanisms by which MIR4435-2HG promotes UCB progression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that\u00a0MIR4435-2HG was significantly upregulated in the stromal-enriched subtype of UCB. Increased MIR4435-2HG expression was positively correlated with a high histological grade, advanced T stages, larger tumors, lymph node metastasis and a\u00a0poor prognosis. <jats:italic>In vitro<\/jats:italic> experiments revealed that MIR4435-2HG expression\u00a0silencing suppressed cell proliferation and induced apoptosis. Inhibition of MIR4434-2HG delayed xenograft tumor growth, while MIR4435-2HG overexpression reversed the MIR4435-2HG silencing-induced inhibition of UCB tumor phenotype acquisition. Mechanistically, we found that MIR4435-2HG positively regulated the expression of a variety of cell cycle regulators, including BRCA2 and CCND1. Knocking down MIR4435-2HG increased the sensitivity of tumor cells to the VEGFR inhibitor cediranib. Furthermore, we found that MIR4435-2HG regulated mTOR signaling and epithelial-mesenchymal transition (EMT) signaling pathways by modulating the phosphorylation of mTOR, 70S6K and 4EBP1. Finally, we confirmed that MIR4435-2HG enhances tumor metastasis through regulation of the EMT pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data indicate that\u00a0upregulated MIR4435-2HG expression levels are significantly correlated with a\u00a0poor prognosis of UCB patients. MIR4435-2HG promotes bladder cancer progression, mediates cell cycle (de)regulation and modulates mTOR signaling. MIR4435-2HG is an oncogenic lncRNA in UCB that may serve as a diagnostic and therapeutic target.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s13402-023-00826-5","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T17:02:36Z","timestamp":1687626156000},"page":"1509-1527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder"],"prefix":"10.1007","volume":"46","author":[{"given":"Lu","family":"Pei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglian","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongqiong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haide","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,24]]},"reference":[{"issue":"1","key":"826_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"R.L. Siegel, K.D. Miller, H.E. Fuchs, A. Jemal, Cancer Statistics, 2021. CA Cancer J. Clin. 71(1), 7\u201333 (2021)","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"826_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68(6), 394\u2013424 (2018)","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"826_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrclinonc.2016.188","volume":"14","author":"SA Funt","year":"2017","unstructured":"S.A. Funt, J.E. Rosenberg, Systemic, perioperative management of muscle-invasive bladder cancer and future horizons. Nat. Rev. Clin. Oncol. 14(4), 221\u2013234 (2017)","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"826_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.eururo.2018.08.027","volume":"75","author":"TZ Tan","year":"2019","unstructured":"T.Z. Tan, M. Rouanne, K.T. Tan, R.Y. Huang, J.P. Thiery, Molecular subtypes of urothelial bladder cancer: results from a meta-cohort analysis of 2411 tumors. Eur. Urol. 75(3), 423\u2013432 (2019)","journal-title":"Eur. Urol."},{"issue":"10061","key":"826_CR5","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"A.M. Kamat, N.M. Hahn, J.A. Efstathiou, S.P. Lerner, P.U. Malmstrom, W. Choi et al., Bladder cancer. Lancet 388(10061), 2796\u20132810 (2016)","journal-title":"Lancet"},{"issue":"3","key":"826_CR6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"A.G. Robertson, J. Kim, H. Al-Ahmadie, J. Bellmunt, G. Guo, A.D. Cherniack et al., Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 171(3), 540\u201356 e25 (2017)","journal-title":"Cell"},{"issue":"7693","key":"826_CR7","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"S. Mariathasan, S.J. Turley, D. Nickles, A. Castiglioni, K. Yuen, Y. Wang et al., TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554(7693), 544\u2013548 (2018)","journal-title":"Nature"},{"key":"826_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-genet-120213-092323","volume":"48","author":"R Bonasio","year":"2014","unstructured":"R. Bonasio, R. Shiekhattar, Regulation of transcription by long noncoding RNAs. Annu. Rev. Genet. 48, 433\u2013455 (2014)","journal-title":"Annu. Rev. Genet."},{"issue":"2","key":"826_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ymthe.2018.12.015","volume":"27","author":"Z Chen","year":"2019","unstructured":"Z. Chen, X. Chen, R. Xie, M. Huang, W. Dong, J. Han et al., DANCR promotes metastasis and proliferation in bladder cancer cells by enhancing IL-11-STAT3 signaling and CCND1 expression. Mol. Ther. 27(2), 326\u2013341 (2019)","journal-title":"Mol. Ther."},{"issue":"10","key":"826_CR10","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/1878-0261.12746","volume":"14","author":"Y Hayashi","year":"2020","unstructured":"Y. Hayashi, K. Fujita, S. Nojima, E. Tomiyama, M. Matsushita, Y. Koh et al., TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancer. Mol. Oncol. 14(10), 2375\u20132383 (2020)","journal-title":"Mol. Oncol."},{"issue":"1","key":"826_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13046-020-01624-9","volume":"39","author":"Y Zhan","year":"2020","unstructured":"Y. Zhan, L. Zhang, S. Yu, J. Wen, Y. Liu, X. Zhang, Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6\/Wnt\/beta-catenin signaling pathway in bladder cancer. J. Exp. Clin. Cancer Res. 39(1), 136 (2020)","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"826_CR12","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.eururo.2013.12.003","volume":"65","author":"ES Martens-Uzunova","year":"2014","unstructured":"E.S. Martens-Uzunova, R. Bottcher, C.M. Croce, G. Jenster, T. Visakorpi, G.A. Calin, Long noncoding RNA in prostate, bladder, and kidney cancer. Eur. Urol. 65(6), 1140\u20131151 (2014)","journal-title":"Eur. Urol."},{"issue":"8","key":"826_CR13","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3390\/genes13081462","volume":"13","author":"Z Hu","year":"2022","unstructured":"Z. Hu, S. Ma, Y. Sun, G. Long, K. Chen, Identification of long non-coding RNA MIR4435\u20132HG as a prognostic biomarker in bladder cancer. Genes (Basel) 13(8), 1462 (2022)","journal-title":"Genes (Basel)"},{"key":"826_CR14","doi-asserted-by":"publisher","first-page":"3858249","DOI":"10.1155\/2022\/3858249","volume":"2022","author":"T Yang","year":"2022","unstructured":"T. Yang, Y. Li, G. Wang, L. Guo, F. Sun, S. Li et al., lncRNA MIR4435-2HG accelerates the development of bladder cancer through enhancing IQGAP3 and CDCA5 expression. Biomed. Res. Int. 2022, 3858249 (2022)","journal-title":"Biomed. Res. Int."},{"issue":"7","key":"826_CR15","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/jcmm.12999","volume":"21","author":"X Chen","year":"2017","unstructured":"X. Chen, P. Gu, R. Xie, J. Han, H. Liu, B. Wang et al., Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer. J. Cell Mol. Med. 21(7), 1266\u20131279 (2017)","journal-title":"J. Cell Mol. Med."},{"key":"826_CR16","doi-asserted-by":"crossref","unstructured":"A.R. Kaplan, S.E. Gueble, Y. Liu, S. Oeck, H. Kim, Z. Yun et al., Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1\/2 and RAD51. Sci. Transl. Med. 11(492), eaav4508 (2019)","DOI":"10.1126\/scitranslmed.aav4508"},{"key":"826_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.canlet.2018.01.027","volume":"421","author":"H Yan","year":"2018","unstructured":"H. Yan, P. Bu, Non-coding RNAs in cancer stem cells. Cancer Lett. 421, 121\u2013126 (2018)","journal-title":"Cancer Lett."},{"issue":"2","key":"826_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.cell.2015.02.045","volume":"161","author":"DF Lee","year":"2015","unstructured":"D.F. Lee, J. Su, H.S. Kim, B. Chang, D. Papatsenko, R. Zhao et al., Modeling familial cancer with induced pluripotent stem cells. Cell 161(2), 240\u2013254 (2015)","journal-title":"Cell"},{"issue":"7","key":"826_CR19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41568-021-00353-1","volume":"21","author":"SJ Liu","year":"2021","unstructured":"S.J. Liu, H.X. Dang, D.A. Lim, F.Y. Feng, C.A. Maher, Long noncoding RNAs in cancer metastasis. Nat. Rev. Cancer. 21(7), 446\u2013460 (2021)","journal-title":"Nat. Rev. Cancer."},{"issue":"4","key":"826_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"A.M. Schmitt, H.Y. Chang, Long noncoding RNAs in cancer pathways. Cancer Cell 29(4), 452\u2013463 (2016)","journal-title":"Cancer Cell"},{"issue":"17","key":"826_CR21","doi-asserted-by":"publisher","first-page":"10013","DOI":"10.1111\/jcmm.15609","volume":"24","author":"K Zhu","year":"2020","unstructured":"K. Zhu, C. Miao, Y. Tian, Z. Qin, J. Xue, J. Xia et al., lncRNA MIR4435-2HG promoted clear cell renal cell carcinoma malignant progression via miR-513a-5p\/KLF6 axis. J. Cell Mol. Med. 24(17), 10013\u201310026 (2020)","journal-title":"J. Cell Mol. Med."},{"issue":"11","key":"826_CR22","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1111\/jcmm.15280","volume":"24","author":"H Xu","year":"2020","unstructured":"H. Xu, B. Zhang, Y. Yang, Z. Li, P. Zhao, W. Wu et al., LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p\/TGFBR2 axis. J. Cell Mol. Med. 24(11), 6362\u20136372 (2020)","journal-title":"J. Cell Mol. Med."},{"key":"826_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12935-020-01227-6","volume":"20","author":"L Zhu","year":"2020","unstructured":"L. Zhu, A. Wang, M. Gao, X. Duan, Z. Li, LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p\/CKD14 axis. Cancer Cell Int. 20, 145 (2020)","journal-title":"Cancer Cell Int."},{"key":"826_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fonc.2020.00160","volume":"10","author":"X Dong","year":"2020","unstructured":"X. Dong, Z. Yang, H. Yang, D. Li, X. Qiu, Long non-coding RNA MIR4435-2HG promotes colorectal cancer proliferation and metastasis through miR-206\/YAP1 Axis. Front. Oncol. 10, 160 (2020)","journal-title":"Front. Oncol."},{"issue":"10","key":"826_CR25","first-page":"6381","volume":"12","author":"X Shen","year":"2020","unstructured":"X. Shen, Y. Ding, F. Lu, H. Yuan, W. Luan, Long noncoding RNA MIR4435-2HG promotes hepatocellular carcinoma proliferation and metastasis through the miR-22-3p\/YWHAZ axis. Am. J. Transl. Res. 12(10), 6381\u20136394 (2020)","journal-title":"Am. J. Transl. Res."},{"key":"826_CR26","doi-asserted-by":"publisher","first-page":"661288","DOI":"10.3389\/fonc.2021.661288","volume":"11","author":"LF Gao","year":"2021","unstructured":"L.F. Gao, W. Li, Y.G. Liu, C. Zhang, W.N. Gao, L. Wang, Inhibition of MIR4435-2HG on invasion, migration, and EMT of gastric carcinoma cells by mediating MiR-138-5p\/Sox4 axis. Front. Oncol. 11, 661288 (2021)","journal-title":"Front. Oncol."},{"issue":"8","key":"826_CR27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00109-018-1654-5","volume":"96","author":"H Qian","year":"2018","unstructured":"H. Qian, L. Chen, J. Huang, X. Wang, S. Ma, F. Cui et al., The lncRNA MIR4435-2HG promotes lung cancer progression by activating beta-catenin signalling. J. Mol. Med. (Berl) 96(8), 753\u2013764 (2018)","journal-title":"J. Mol. Med. (Berl)"},{"key":"826_CR28","doi-asserted-by":"crossref","unstructured":"C.A. Hartana, Y. Rassadkina, C. Gao, E. Martin-Gayo, B.D. Walker, M. Lichterfeld et al., Long noncoding RNA MIR4435\u20132HG enhances metabolic function of myeloid dendritic cells from HIV-1 elite controllers. J. Clin. Invest. 131(9), e146136 (2021)","DOI":"10.1172\/JCI146136"},{"key":"826_CR29","doi-asserted-by":"crossref","unstructured":"H.T. Liu, Y.X. Zou, W.J. Zhu, L. Sen, G.H. Zhang, R.R. Ma et al., lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus. Cell Death Differ. 29(3), 627\u2013641 (2022)","DOI":"10.1038\/s41418-021-00879-9"},{"issue":"12","key":"826_CR30","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/s41588-018-0252-3","volume":"50","author":"J Kim","year":"2018","unstructured":"J. Kim, H.L. Piao, B.J. Kim, F. Yao, Z. Han, Y. Wang et al., Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 50(12), 1705\u20131715 (2018)","journal-title":"Nat Genet."},{"issue":"1","key":"826_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12943-019-1079-y","volume":"18","author":"W Ni","year":"2019","unstructured":"W. Ni, S. Yao, Y. Zhou, Y. Liu, P. Huang, A. Zhou et al., Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m(6)A reader YTHDF3. Mol. Cancer. 18(1), 143 (2019)","journal-title":"Mol. Cancer."},{"issue":"1","key":"826_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-019-1107-y","volume":"18","author":"J Yang","year":"2019","unstructured":"J. Yang, Q. Qiu, X. Qian, J. Yi, Y. Jiao, M. Yu et al., Long noncoding RNA LCAT1 functions as a ceRNA to regulate RAC1 function by sponging miR-4715-5p in lung cancer. Mol Cancer. 18(1), 171 (2019)","journal-title":"Mol Cancer."},{"key":"826_CR33","doi-asserted-by":"crossref","unstructured":"K.B. Kuchenbaecker, L. McGuffog, D. Barrowdale, A. Lee, P. Soucy, J. Dennis et al., Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers. J. Natl. Cancer Inst. 109(7), djw302 (2017)","DOI":"10.1093\/jnci\/djw302"},{"issue":"1","key":"826_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.eururo.2019.08.025","volume":"77","author":"T Nyberg","year":"2020","unstructured":"T. Nyberg, D. Frost, D. Barrowdale, D.G. Evans, E. Bancroft, J. Adlard et al., Prostate cancer risks for male BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Eur. Urol. 77(1), 24\u201335 (2020)","journal-title":"Eur. Urol."},{"issue":"1","key":"826_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12916-021-01925-6","volume":"19","author":"KH Ho","year":"2021","unstructured":"K.H. Ho, T.W. Huang, C.M. Shih, Y.T. Lee, A.J. Liu, P.H. Chen et al., Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment. BMC Med. 19(1), 59 (2021)","journal-title":"BMC Med."},{"issue":"2","key":"826_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.devcel.2020.06.018","volume":"54","author":"F Li","year":"2020","unstructured":"F. Li, M.C. Simon, Cancer cells don\u2019t live alone: metabolic communication within tumor microenvironments. Dev. Cell. 54(2), 183\u2013195 (2020)","journal-title":"Dev. Cell."},{"issue":"6427","key":"826_CR37","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.aav0173","volume":"363","author":"CK Lee","year":"2019","unstructured":"C.K. Lee, S.H. Jeong, C. Jang, H. Bae, Y.H. Kim, I. Park et al., Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation. Science 363(6427), 644\u2013649 (2019)","journal-title":"Science"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-023-00826-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-023-00826-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-023-00826-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:43:00Z","timestamp":1698781380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-023-00826-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,24]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["826"],"URL":"https:\/\/doi.org\/10.1007\/s13402-023-00826-5","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,24]]},"assertion":[{"value":"2 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of the Sun Yat-sen Memorial Hospital of Sun Yat-sen University (SYSU). Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}